Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy

• Wolfgang Peter Fendler ,

  * E-mail: wolfgang.fendler@med.uni-muenchen.de

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Vera Wenter,

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Henriette Ingrid Thornton,

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Harun Ilhan,

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Dietrich von Schweinitz,

  Affiliation Department of Pediatric Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Eva Coppenrath,

  Affiliation Institute of Clinical Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Irene Schmid,

  Affiliation Department of Pediatric Haematology and Oncology, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Peter Bartenstein,

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯
• Thomas Pfluger

  Affiliation Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

  ⨯